SNY

Sanofi ADS
D

SNY

Arincen75/100B
47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
OverviewFinancialsForecastEarningsDividendsCompany

Sanofi ADS shares outstanding 1999–2026

Sanofi ADS had 2,407,843,014 shares outstanding on 8 November 2026. Sanofi ADS had 2.41B diluted shares on average over the last twelve months, down 2.7% on the twelve months before. In fiscal year 2025 the average was 2.44B.

Last updated 9 Nov 2026 · Next report 4 Feb 2027

Shares outstanding

Change on the year

Fiscal yearPeriod endingShares outstandingChange on the yearBasic shares
TTM30 Sept 20262.41B-2.71%2.41B
FY202531 Dec 20252.44B-2.48%2.44B
FY202431 Dec 20242.50B-0.40%2.50B
FY202331 Dec 20232.51B+0.36%2.50B
FY202231 Dec 20222.50B-0.05%2.50B
FY202131 Dec 20212.51B-0.09%2.51B
FY202031 Dec 20202.51B+0.30%2.51B
FY201931 Dec 20192.50B+0.22%2.50B
FY201831 Dec 20182.49B-0.78%2.49B
FY201731 Dec 20172.51B-2.31%2.51B
FY201631 Dec 20162.57B-1.50%2.57B
FY201531 Dec 20152.61B-0.73%2.61B
FY201431 Dec 20142.63B-0.55%2.63B
FY201331 Dec 20132.65B+0.27%2.65B
FY201231 Dec 20122.64B-0.17%2.64B
FY201131 Dec 20112.64B+1.26%2.64B
FY201031 Dec 20102.61B-0.09%2.61B
FY200931 Dec 20092.61B-0.71%2.61B
FY200831 Dec 20082.63B-2.81%2.62B
FY200731 Dec 20072.71B-0.36%2.69B
FY200631 Dec 20062.72B+0.91%2.69B
FY200531 Dec 20052.69B+47.19%2.67B
FY200431 Dec 20041.83B+29.74%1.82B
FY200331 Dec 20031.41B-3.31%1.41B
FY200231 Dec 20021.46B-0.33%1.46B
FY200131 Dec 20011.46B+0.07%1.46B
FY200031 Dec 20001.46B+0.06%1.46B
FY199931 Dec 19991.46B—1.46B

Figures in EUR. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Sanofi ADS's shares

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.